Bright Minds Biosciences Inc.

NASDAQ (USD): Bright Minds Biosciences Inc. (DRUG)

Last Price

38.65

Today's Change

-0.46 (1.17%)

Day's Change

36.80 - 39.10

Trading Volume

51,445

Overview

Market Cap

268 Million

Shares Outstanding

6 Million

Avg Volume

3,062,801

Avg Price (50 Days)

39.53

Avg Price (200 Days)

10.75

PE Ratio

-63.36

EPS

-0.61

Earnings Announcement

03-Jan-2025

Previous Close

39.11

Open

38.39

Day's Range

36.8093 - 39.1

Year Range

0.93 - 79.02

Trading Volume

51,471

Price Change Highlight

1 Day Change

-1.18%

5 Day Change

-6.46%

1 Month Change

19.36%

3 Month Change

2992.00%

6 Month Change

3580.95%

Ytd Change

2000.54%

1 Year Change

2584.03%

3 Year Change

130.75%

5 Year Change

43.15%

10 Year Change

43.15%

Max Change

43.15%

News and Blogs
Latest Hottest Following

No result.

Company Profile

Sector: Healthcare - Healthcare

Industry: Biotechnology

Description:

Bright Minds Biosciences Inc., a pre-clinical biosciences company, develops 5-HT (serotonin) medicines to improve the lives of patients with severe and life-altering diseases. Its portfolio of selective 5-HT receptor agonists comprises 5-HT2C, 5-HT2A, and 5-HT2C/A for the treatment of epilepsy, pain, and neuropsychiatry. The company has collaboration with National Institutes of Health for the treatment of epilepsy; University of Texas Medical Branch to treat impulse control disorders, such as binge eating; and Medical College of Wisconsin. The company was incorporated in 2019 and is headquartered in Vancouver, Canada.

Discussions
Be the first to like this. Showing 0 of 0 comments
Post a Comment